The Functional Role of Alzheimer Risk Loci in Disease Progression

Abstract

Understanding the regulatory mechanisms that drive Alzheimer’s disease (AD) is critical for translating genetic risk into possible therapeutics. This review of a study published in Cell by Xiong et al. provides a comprehensive, cell-type-specific analysis of the AD brain’s epigenomic and transcriptional landscape, offering a foundational framework for interpreting noncoding genetic variants. By linking regulatory elements to gene expression through multimodal single-nucleus sequencing, the work highlights how disruptions in chromatin accessibility contribute to disease progression and cellular identity loss. Its significance lies not just in the findings, but in its broader impact, which is demonstrating how integrative, high-resolution approaches can uncover the regulatory circuitry underlying neurodegeneration. This has profound implications for precision medicine, as it enables researchers to move beyond association studies and toward mechanistic models of AD that can inform targeted therapies. The study also raises essential questions about the role of epigenomic erosion in neuronal decline, pointing to chromatin-modifying enzymes and regulatory instability as potential intervention points. Ultimately, this research shifts the focus from static genetic risk to dynamic regulatory dysfunction, setting the stage for systems-level exploration of complex brain diseases.